1. Home
  2. RNXT vs ENZ Comparison

RNXT vs ENZ Comparison

Compare RNXT & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • ENZ
  • Stock Information
  • Founded
  • RNXT 2012
  • ENZ 1976
  • Country
  • RNXT United States
  • ENZ United States
  • Employees
  • RNXT N/A
  • ENZ N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • ENZ Medical Specialities
  • Sector
  • RNXT Health Care
  • ENZ Health Care
  • Exchange
  • RNXT Nasdaq
  • ENZ Nasdaq
  • Market Cap
  • RNXT 31.6M
  • ENZ 34.2M
  • IPO Year
  • RNXT 2021
  • ENZ N/A
  • Fundamental
  • Price
  • RNXT $1.12
  • ENZ $0.52
  • Analyst Decision
  • RNXT Strong Buy
  • ENZ
  • Analyst Count
  • RNXT 1
  • ENZ 0
  • Target Price
  • RNXT $9.00
  • ENZ N/A
  • AVG Volume (30 Days)
  • RNXT 202.5K
  • ENZ 125.3K
  • Earning Date
  • RNXT 03-31-2025
  • ENZ 03-12-2025
  • Dividend Yield
  • RNXT N/A
  • ENZ N/A
  • EPS Growth
  • RNXT N/A
  • ENZ N/A
  • EPS
  • RNXT N/A
  • ENZ N/A
  • Revenue
  • RNXT N/A
  • ENZ $30,314,000.00
  • Revenue This Year
  • RNXT N/A
  • ENZ N/A
  • Revenue Next Year
  • RNXT N/A
  • ENZ N/A
  • P/E Ratio
  • RNXT N/A
  • ENZ N/A
  • Revenue Growth
  • RNXT N/A
  • ENZ N/A
  • 52 Week Low
  • RNXT $0.77
  • ENZ $0.51
  • 52 Week High
  • RNXT $1.86
  • ENZ $1.40
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 36.31
  • ENZ 22.58
  • Support Level
  • RNXT $1.09
  • ENZ $0.56
  • Resistance Level
  • RNXT $1.40
  • ENZ $0.69
  • Average True Range (ATR)
  • RNXT 0.10
  • ENZ 0.03
  • MACD
  • RNXT -0.03
  • ENZ -0.00
  • Stochastic Oscillator
  • RNXT 8.51
  • ENZ 8.13

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

Share on Social Networks: